The ESMO2025 (European Society for Medical Oncology) congress on the latest updates and developments in the field has been taking place in Berlin from October 17th to 21st.
BD4QoL participated by submitting an abstract on the Prospective Clinical Study and its preliminary results: after the acceptance of the abstract INT Dr. Stefano Cavalieri has been invited to present it at the session dedicated to head and neck cancers, “Paper Session 2: Head and Neck Cancer”.
On october 20th, in the Dortmund Auditorium-Hall 7.1a, Dr. Cavalieri presented the BD4QoL Study to international colleagues, illustrating the main methodological, technical and scientific characteristics of the projects and showing the audience the first analyses and results on the main objective of the study itself.